ENDRA Life Sciences (NDRA) Assets Average (2017 - 2026)

ENDRA Life Sciences (NDRA) has reported Assets Average for 10 consecutive years, with $5.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average rose 90.36% year-over-year to $5.7 million in Q2 2026; TTM through Jun 2026 was $5.7 million, a 90.36% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, down 39.56% from the prior year.
• Assets Average was $5.7 million for Q2 2026 at ENDRA Life Sciences, up from $3.6 million in the prior quarter.
• Over five years, Assets Average peaked at $13.8 million in Q3 2022 and troughed at $403892.0 in Q4 2024.
• A 5-year average of $6.7 million and a median of $6.5 million in 2023 frame the typical range for Assets Average.
• Across the five-year window, Assets Average plunged 94.37% in 2024 and surged 620.23% in 2025, its largest moves.
• Over 5 years, Assets Average stood at $10.8 million in 2022, then slumped by 33.58% to $7.2 million in 2023, then sank by 94.37% to $403892.0 in 2024, then surged by 620.23% to $2.9 million in 2025, then surged by 95.61% to $5.7 million in 2026.
• The last three Assets Average figures came in at $5.7 million (Q2 2026), $3.6 million (Q1 2026), and $2.9 million (Q4 2025), per Business Quant data.